Nutrivert
Atlanta, US · Delaware corporation
Founders & leadership
HN
Horace NalleExecutive
PS
Peter SeloverExecutive
BK
Bernhard KaltenboeckNamed on SEC filing
JQ
Jonathon QuigleyNamed on SEC filing
Board
TM
Troy MerryBoard director
Reported raises · per SEC filings
Form D private placements$3.9M disclosed across 2 rounds · 2023–2026
▶$2.4MraisedApr 2026 · 2 investors · PharmaceuticalsRule 506(b)
▶$2.4MraisedApr 2026 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bernhard KaltenboeckExecutive Officer, Director
- Horace NalleExecutive Officer, Director
- Troy MerryDirector
- Peter SeloverExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $2.4M
- Proceeds to insiders
- $735K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMar 2023 · 1 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedMar 2023 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Horace NalleExecutive Officer, Director
- Peter SeloverExecutive Officer, Director
- Jonathon QuigleyDirector
- Bernhard KaltenboeckExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.5M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Nutrivert raised?
- Nutrivert has disclosed $3.9M raised across 2 rounds.
- Where is Nutrivert headquartered?
- Nutrivert is headquartered in Atlanta, US.